07/2013 - Državni zavod za intelektualno vlasništvo
07/2013 - Državni zavod za intelektualno vlasništvo
07/2013 - Državni zavod za intelektualno vlasništvo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2224 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 20, <strong>2013</strong>, 7, 2169 – 2293MKP Broj objave europske Naziv izumaprijave patenta(51) (97) (54)C<strong>07</strong>D 401/12 (2006.01) EP 2610244 Indole compoundsSynthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrileC<strong>07</strong>D 401/14 (2006.01) EP 2535338C<strong>07</strong>D 401/14 (2006.01) EP 2610244 Indole compoundsC<strong>07</strong>D 403/06 (2006.01) EP 2610244 Indole compoundsC<strong>07</strong>D 403/14 (2006.01) EP 2610244 Indole compoundsC<strong>07</strong>D 405/12 (2006.01) EP 2301933 Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulatorsC<strong>07</strong>D 405/12 (2006.01) EP 2311827 Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators.C<strong>07</strong>D 405/12 (2006.01) EP 2612858 STAT3/5 activation inhibitorC<strong>07</strong>D 413/04 (2006.01) EP 2522664 Piperidine derivatives as NK1 antagonistsC<strong>07</strong>D 417/14 (2006.01) EP 2610244 Indole compoundsC<strong>07</strong>D 471/04 (2006.01) EP 2468748 Pyrazoloquinolones are potent parp inhibitorsC<strong>07</strong>D 491/04 (2006.01) EP 2468748 Pyrazoloquinolones are potent parp inhibitorsC<strong>07</strong>D 491/04 (2006.01) EP 2518<strong>07</strong>4 Phosphoinositide 3-kinase inhibitor compounds and methods of useC<strong>07</strong>D 493/08 (2006.01) EP 2522663 Intermediates for the preparation of halichondrin BC<strong>07</strong>D 493/18 (2006.01) EP 2522663 Intermediates for the preparation of halichondrin BC<strong>07</strong>D 495/04 (2006.01) EP 2468748 Pyrazoloquinolones are potent parp inhibitorsC<strong>07</strong>D 495/04 (2006.01) EP 2518<strong>07</strong>4 Phosphoinositide 3-kinase inhibitor compounds and methods of useC<strong>07</strong>D 498/04 (2006.01) EP 2610244 Indole compoundsC<strong>07</strong>F 5/02 (2006.01) EP 2527347 Proteasome inhibitorsMethods Using 3-(4-Amino-1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione ForTreatment Of Certain LeukemiasC<strong>07</strong>H 19/20 (2006.01) EP 2526946C<strong>07</strong>H 21/00 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC<strong>07</strong>K 16/00 (2006.01) EP 2527425 Cell culture improvementsC<strong>07</strong>K 16/16 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC<strong>07</strong>K 16/18 (2006.01) EP 2500030 Use of complement pathway inhibitors to treat ocular diseasesC<strong>07</strong>K 16/24 (2006.01) EP 2520588 Dual variable domain immunoglobulin and uses thereofC<strong>07</strong>K 16/24 (2006.01) EP 2527370 Compounds having resistance to soluble CEAC<strong>07</strong>K 16/28 (2006.01) EP 2520588 Dual variable domain immunoglobulin and uses thereofC<strong>07</strong>K 16/30 (2006.01) EP 2527370 Compounds having resistance to soluble CEAC<strong>07</strong>K 16/40 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC<strong>07</strong>K 16/46 (2006.01) EP 2520588 Dual variable domain immunoglobulin and uses thereofC<strong>07</strong>K 17/00 (2006.01) EP 2500030 Use of complement pathway inhibitors to treat ocular diseasesC12N 13/00 (2006.01) EP 2602326 Methods for transfecting nucleic acids into live cellsC12N 15/11 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12N 15/12 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12N 15/52 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12N 15/63 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12N 15/85 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12N 15/86 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12N 15/87 (2006.01) EP 2602326 Methods for transfecting nucleic acids into live cellsC12N 5/00 (2006.01) EP 2527425 Cell culture improvementsC12N 5/02 (2006.01) EP 2527425 Cell culture improvementsC12N 5/<strong>07</strong>4 (2010.01) EP 2471904 Placental stem cell populationsC12N 5/<strong>07</strong>4 (2010.01) EP 2471905 Placental stem cell populationsC12N 5/<strong>07</strong>4 (2010.01) EP 2471906 Placental stem cell populationsC12N 5/<strong>07</strong>4 (2010.01) EP 24719<strong>07</strong> Placental stem cell populationsC12N 5/16 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12N 5/22 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12N 9/12 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12N 9/48 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12P 21/04 (2006.01) EP 2520310 Cellular permissivity factor for viruses, and uses thereofC12P 21/06 (2006.01) EP 2520310 Cellular permissivity factor for viruses, and uses thereofC12Q 1/48 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinC12Q 1/68 (2006.01) EP 2275571 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumoursC12Q 1/70 (2006.01) EP 2520310 Cellular permissivity factor for viruses, and uses thereofC12Q 1/70 (2006.01) EP 2578229 Decreasing potential iatrogenic risks associated with vaccine antigensG01N 33/567 (2006.01) EP 2520310 Cellular permissivity factor for viruses, and uses thereofG01N 33/68 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinISSN 1847-3024
Change language